Real-world safety assessment of Mpox Vaccine in Catalonia: Retrospective Cohort Study of Adverse Events of Special Interest and Breakthrough Infections
Mpox vaccination with the Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine has been used to protect people at increased risk of infection, but real-world safety data from Europe remain limited. We conducted a retrospective cohort study of 8,039 adults in Catalonia, Spain, who received at least one MVA-BN dose between June 13, 2022 and December 31, 2024, using routinely collected primary care and linked hospital records. We looked for five prespecified adverse events of special interest (myocarditis, pericarditis, thrombocytopenia, anaphylaxis and generalized convulsive seizure) within 28 days after each dose, and described mpox infections diagnosed after vaccination. Participants were predominantly men (97.7%) and aged 26–45 years (68.0%). Adverse events were rare: fewer than five cases of pericarditis occurred within 28 days of vaccination (day 19 after the first dose), and no other event of special interest was identified in that window. Sixteen participants (0.20%; 95% confidence interval 0.11–0.32%) had a recorded mpox diagnosis after vaccination. These findings provide preliminary, region-specific reassurance about the short-term safety of MVA-BN. However, events were few, there was no unvaccinated comparison group, and the study cannot establish causality or vaccine effectiveness. Continued monitoring of vaccine safety is warranted.
Authors
- Irma Convertino (ORCID: https://orcid.org/0000-0002-7883-3657)
- Felipe Villalobos (ORCID: https://orcid.org/0000-0002-6907-8354)
- Martín Solórzano (ORCID: https://orcid.org/0000-0001-9628-9256)
- Aaron Switzer Rodriguez¹˒²
- Marc Far¹
- Víctor Roigé-Peña¹
Institutions
- University of Pisa (IT)
- Universitat Pompeu Fabra (ES)
- Institut Universitari d'Investigació en Atenció Primària Jordi Gol (ES)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-20
- DOI
- https://doi.org/10.21203/rs.3.rs-11692999/v1
- Primary Topic
- Poxvirus research and outbreaks
- Type
- preprint